Cargando…
Effectiveness and Tolerability of Oral Amoxicillin in Pregnant Women with Active Syphilis, Japan, 2010–2018
We conducted a nationwide retrospective study in Japan to evaluate the effectiveness of oral amoxicillin or ampicillin as alternatives to injectable benzathine penicillin G for treating pregnant women with syphilis and preventing congenital syphilis (CS). We investigated 80 pregnant women with activ...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258477/ https://www.ncbi.nlm.nih.gov/pubmed/32441638 http://dx.doi.org/10.3201/eid2606.191300 |
_version_ | 1783540090163691520 |
---|---|
author | Nishijima, Takeshi Kawana, Kei Fukasawa, Ichio Ishikawa, Naoko Taylor, Melanie M. Mikamo, Hiroshige Kato, Kiyoko Kitawaki, Jo Fujii, Tomoyuki |
author_facet | Nishijima, Takeshi Kawana, Kei Fukasawa, Ichio Ishikawa, Naoko Taylor, Melanie M. Mikamo, Hiroshige Kato, Kiyoko Kitawaki, Jo Fujii, Tomoyuki |
author_sort | Nishijima, Takeshi |
collection | PubMed |
description | We conducted a nationwide retrospective study in Japan to evaluate the effectiveness of oral amoxicillin or ampicillin as alternatives to injectable benzathine penicillin G for treating pregnant women with syphilis and preventing congenital syphilis (CS). We investigated 80 pregnant women with active syphilis treated with amoxicillin or ampicillin during 2010–2018. Overall, 21% (15/71) had pregnancies resulting in CS cases, and 3.8% (3/80) changed therapies because of side effects. Among 26 patients with early syphilis, no CS cases occurred, but among 45 with late syphilis, 15 (33%) CS cases occurred. Among 57 patients who started treatment >60 days before delivery, 8 (14%) had CS pregnancy outcomes. We found oral amoxicillin potentially ineffective for preventing CS cases among pregnant women with late syphilis but potentially effective in those with early syphilis. Prospective studies are needed to definitively evaluate the efficacy of amoxicillin for the treatment of pregnant women with syphilis to prevent CS. |
format | Online Article Text |
id | pubmed-7258477 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-72584772020-06-09 Effectiveness and Tolerability of Oral Amoxicillin in Pregnant Women with Active Syphilis, Japan, 2010–2018 Nishijima, Takeshi Kawana, Kei Fukasawa, Ichio Ishikawa, Naoko Taylor, Melanie M. Mikamo, Hiroshige Kato, Kiyoko Kitawaki, Jo Fujii, Tomoyuki Emerg Infect Dis Research We conducted a nationwide retrospective study in Japan to evaluate the effectiveness of oral amoxicillin or ampicillin as alternatives to injectable benzathine penicillin G for treating pregnant women with syphilis and preventing congenital syphilis (CS). We investigated 80 pregnant women with active syphilis treated with amoxicillin or ampicillin during 2010–2018. Overall, 21% (15/71) had pregnancies resulting in CS cases, and 3.8% (3/80) changed therapies because of side effects. Among 26 patients with early syphilis, no CS cases occurred, but among 45 with late syphilis, 15 (33%) CS cases occurred. Among 57 patients who started treatment >60 days before delivery, 8 (14%) had CS pregnancy outcomes. We found oral amoxicillin potentially ineffective for preventing CS cases among pregnant women with late syphilis but potentially effective in those with early syphilis. Prospective studies are needed to definitively evaluate the efficacy of amoxicillin for the treatment of pregnant women with syphilis to prevent CS. Centers for Disease Control and Prevention 2020-06 /pmc/articles/PMC7258477/ /pubmed/32441638 http://dx.doi.org/10.3201/eid2606.191300 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Nishijima, Takeshi Kawana, Kei Fukasawa, Ichio Ishikawa, Naoko Taylor, Melanie M. Mikamo, Hiroshige Kato, Kiyoko Kitawaki, Jo Fujii, Tomoyuki Effectiveness and Tolerability of Oral Amoxicillin in Pregnant Women with Active Syphilis, Japan, 2010–2018 |
title | Effectiveness and Tolerability of Oral Amoxicillin in Pregnant Women with Active Syphilis, Japan, 2010–2018 |
title_full | Effectiveness and Tolerability of Oral Amoxicillin in Pregnant Women with Active Syphilis, Japan, 2010–2018 |
title_fullStr | Effectiveness and Tolerability of Oral Amoxicillin in Pregnant Women with Active Syphilis, Japan, 2010–2018 |
title_full_unstemmed | Effectiveness and Tolerability of Oral Amoxicillin in Pregnant Women with Active Syphilis, Japan, 2010–2018 |
title_short | Effectiveness and Tolerability of Oral Amoxicillin in Pregnant Women with Active Syphilis, Japan, 2010–2018 |
title_sort | effectiveness and tolerability of oral amoxicillin in pregnant women with active syphilis, japan, 2010–2018 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258477/ https://www.ncbi.nlm.nih.gov/pubmed/32441638 http://dx.doi.org/10.3201/eid2606.191300 |
work_keys_str_mv | AT nishijimatakeshi effectivenessandtolerabilityoforalamoxicillininpregnantwomenwithactivesyphilisjapan20102018 AT kawanakei effectivenessandtolerabilityoforalamoxicillininpregnantwomenwithactivesyphilisjapan20102018 AT fukasawaichio effectivenessandtolerabilityoforalamoxicillininpregnantwomenwithactivesyphilisjapan20102018 AT ishikawanaoko effectivenessandtolerabilityoforalamoxicillininpregnantwomenwithactivesyphilisjapan20102018 AT taylormelaniem effectivenessandtolerabilityoforalamoxicillininpregnantwomenwithactivesyphilisjapan20102018 AT mikamohiroshige effectivenessandtolerabilityoforalamoxicillininpregnantwomenwithactivesyphilisjapan20102018 AT katokiyoko effectivenessandtolerabilityoforalamoxicillininpregnantwomenwithactivesyphilisjapan20102018 AT kitawakijo effectivenessandtolerabilityoforalamoxicillininpregnantwomenwithactivesyphilisjapan20102018 AT fujiitomoyuki effectivenessandtolerabilityoforalamoxicillininpregnantwomenwithactivesyphilisjapan20102018 AT effectivenessandtolerabilityoforalamoxicillininpregnantwomenwithactivesyphilisjapan20102018 AT effectivenessandtolerabilityoforalamoxicillininpregnantwomenwithactivesyphilisjapan20102018 |